Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Mapreg, explained in plain language.
This study tested an experimental daily pill called MAP4343 in 126 adults whose depression did not improve with standard antidepressants. The goal was to see if the drug could reduce depressive symptoms over 6 weeks. The trial was a Phase 2 study, meaning it was an early test of …
Phase: PHASE2 • Sponsor: Mapreg • Aim: Symptom relief
Last updated May 13, 2026 16:04 UTC